Amit Gupta

ABFRL board approves preferential issue of Rs 2,400 crore to promoters and QIBs.

ABFRL Approves Bold Rs 2,400 Crore Preferential Issue to Boost Promoters and QIBs

Aditya Birla Fashion and Retail Limited (ABFRL) has approved a preferential issue of shares worth approximately Rs 2,379 crore. This fund-raising move will involve the issuance of shares to the promoter group and qualified institutional buyers (QIBs). The capital raised will result in an increase in Pilani Investment and Industries’ shareholding in ABFRL from its…

Read More
US Stock Futures Market Forecast for January 2025 - CPI Data Insights

US Stock Futures Surge as Investors Await December CPI Report: January 2025 Outlook

US Stock Futures Show Optimism Ahead of December CPI Report US stock futures are showing positive movement as investors await the December Consumer Price Index (CPI) report, set for release on January 15, 2025. This report is crucial for understanding inflation trends and could have significant implications for market expectations and Federal Reserve policy. Investors…

Read More
Renewable Power Stocks Performance on January 14: Waaree Energies, Adani Green, Premier Energies, ACME Solar

Renewable Power Stocks Surge Strongly: Waaree Energies, Adani Green, Premier Energies, ACME Solar Shine on January 14

On January 14, 2025, renewable power stocks are making waves in the market, with prominent companies like Waaree Energies, Adani Green, Premier Energies, and ACME Solar showing significant growth. In line with the overall market sentiment, NIFTY50 gained 0.4%, reaching 23,178.35 points, while SENSEX climbed by 317 points to 76,647. Here’s a look at how…

Read More
Laxmi Dental IPO Day 2: Subscription surpasses 7x, GMP zooms by 33%

Laxmi Dental IPO Day 2: Subscription Surges 7x, GMP Soars 33% – Strong Demand!

The initial public offering (IPO) of Laxmi Dental IPO, which opened for public subscription on Monday, January 13, 2025, continues to attract overwhelming investor interest on its second day. The Rs 698-crore IPO has attracted substantial demand, especially from retail investors. The price band for the offering is set between Rs 407 to Rs 428…

Read More
ITC Hotels shares credited to Demat accounts after demerger allotment.

ITC Hotels Shares Now Credited to Demat Accounts: What Does This Mean for ITC Investors? 2025

If you’re an ITC shareholder, you may have recently noticed something new in your Demat account—ITC Hotels shares! After a long-awaited demerger process, ITC Hotels shares have now been credited to the Demat accounts of eligible ITC shareholders. Here’s what you need to know about this development, including the allotment ratio, the upcoming listing, and…

Read More
: HCLTech shares fall over 9% after disappointing Q3 results, raising concerns about Q4 performance.

HCLTech Shares Plunge Over 9% After Q3 Results: Is It Time to Buy, Sell, or Hold?

Shares of HCLTech, India’s third-largest IT services company, plummeted by over 9% on January 14, 2025, following the release of its Q3 results. Despite largely meeting earnings expectations, a slight upward revision in the company’s revenue guidance for FY25 raised concerns about a potentially weaker-than-expected Q4, dampening market sentiment and causing a significant dip in…

Read More
DMart shares slide 6% post Q3 results, showing a decline in stock performance

DMart Shares Slide 6% Post Q3 Results: Should You Buy, Sell, or Hold?

Shares of Avenue Supermarts, the parent company of DMart, saw a sharp drop of 5.7% on January 13, 2025, following the release of disappointing Q3 results. The DMart share price fell to Rs 3,474, reflecting investor concerns over the retailer’s declining margins and the intense competition in the retail sector. Despite posting a 17.5% year-on-year…

Read More
Biocon Share price rises after US FDA approval of Malaysian insulin facility.

Biocon Share Price Soars 4.5% After US FDA Approval for Malaysian Insulin Facility

Biocon Share Price surged by 4.5% after receiving approval from the US Food and Drug Administration (FDA) for its Malaysian insulin facility, overcoming a significant regulatory hurdle and paving the way for future product launches. This clearance marks an important milestone for Biocon, eliminating past barriers and setting the company up for future expansion. The…

Read More
Back To Top